Catheter Precision VTAK
NYSE VTAK
$0.21 -0.01 (-3.81%)
At close: Aug 20, 2026 · 2:37 PM UTC

Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020)

Catheter Precision (VTAK) posted quarterly Change in Acquisitions & Divestments of $5.0 million for Q2 2020, down 54.55% quarter-over-quarter from $11.0 million in Q1 2020.

Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020) Analysis & Trends

Catheter Precision (VTAK) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $5.0 million the latest figure, recorded in Q2 2020.

  • In Q2 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2020 stood at $16.0 million (changed N/A YoY), while the FY2025 annual figure was $300000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments retreated to $5.0 million in Q2 2020 per VTAK's latest filing, from $11.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $11.0 million in Q1 2020 and bottomed at $5.0 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 Catheter Precision 575,627.53 -1.26 Mn 98,000.00

Historic Data

Download Data
DateValue
Jun 30, 2020 5.00 Mn
Jun 30, 2020 5.00 Mn
Mar 31, 2020 11.00 Mn
Mar 31, 2020 11.00 Mn
Dec 31, 2019 10.00 Mn
Dec 31, 2019 10.00 Mn